http://pharmaexecnews.com Fri, 29 Apr 2011 14:00:12 +0000 http://wordpress.org/?v=2.8.4 en hourly 1 http://pharmaexecnews.com/biotechnology/researchers-identify-gene-responsible-severe-skin-condition-epilepsy-patients/ http://pharmaexecnews.com/biotechnology/researchers-identify-gene-responsible-severe-skin-condition-epilepsy-patients/#comments Wed, 30 Mar 2011 14:00:16 +0000 admin http://pharmaexecnews.com/?p=11391 http://pharmaexecnews.com/biotechnology/researchers-identify-gene-responsible-severe-skin-condition-epilepsy-patients/feed/ 0 http://pharmaexecnews.com/biotechnology/generic-fees-gain-traction-fda-backing/ http://pharmaexecnews.com/biotechnology/generic-fees-gain-traction-fda-backing/#comments Fri, 04 Mar 2011 14:00:10 +0000 admin http://pharmaexecnews.com/?p=11246 http://pharmaexecnews.com/biotechnology/generic-fees-gain-traction-fda-backing/feed/ 0 http://pharmaexecnews.com/biotechnology/senators-resurrect-reimportation-bill/ http://pharmaexecnews.com/biotechnology/senators-resurrect-reimportation-bill/#comments Wed, 02 Mar 2011 14:00:53 +0000 admin http://pharmaexecnews.com/?p=11240 http://pharmaexecnews.com/biotechnology/senators-resurrect-reimportation-bill/feed/ 0 http://pharmaexecnews.com/biotechnology/zymes-receives-michael-fox-foundation-grant-pd-therapy-research/ http://pharmaexecnews.com/biotechnology/zymes-receives-michael-fox-foundation-grant-pd-therapy-research/#comments Tue, 01 Mar 2011 14:00:17 +0000 admin http://pharmaexecnews.com/?p=11237 http://pharmaexecnews.com/biotechnology/zymes-receives-michael-fox-foundation-grant-pd-therapy-research/feed/ 0 http://pharmaexecnews.com/biotechnology/medtrust-avantra-partner-develop-biomarker-assays-cancer/ http://pharmaexecnews.com/biotechnology/medtrust-avantra-partner-develop-biomarker-assays-cancer/#comments Mon, 28 Feb 2011 14:00:33 +0000 admin http://pharmaexecnews.com/?p=11234 http://pharmaexecnews.com/biotechnology/medtrust-avantra-partner-develop-biomarker-assays-cancer/feed/ 0 http://pharmaexecnews.com/biotechnology/rate-drug-approvals-dropping/ http://pharmaexecnews.com/biotechnology/rate-drug-approvals-dropping/#comments Thu, 17 Feb 2011 08:00:22 +0000 admin http://pharmaexecnews.com/?p=11173 http://pharmaexecnews.com/biotechnology/rate-drug-approvals-dropping/feed/ 0 http://pharmaexecnews.com/biotechnology/diabetes-researcher-close-cure/ http://pharmaexecnews.com/biotechnology/diabetes-researcher-close-cure/#comments Tue, 15 Feb 2011 08:00:31 +0000 admin http://pharmaexecnews.com/?p=11164 http://pharmaexecnews.com/biotechnology/diabetes-researcher-close-cure/feed/ 0 http://pharmaexecnews.com/biotechnology/specialty-drugmakers-big-pharma-buy/ http://pharmaexecnews.com/biotechnology/specialty-drugmakers-big-pharma-buy/#comments Mon, 14 Feb 2011 08:00:23 +0000 admin http://pharmaexecnews.com/?p=11160 http://pharmaexecnews.com/biotechnology/specialty-drugmakers-big-pharma-buy/feed/ 0 http://pharmaexecnews.com/biotechnology/court-clears-generic-allegra-sale/ http://pharmaexecnews.com/biotechnology/court-clears-generic-allegra-sale/#comments Wed, 09 Feb 2011 08:00:07 +0000 admin http://pharmaexecnews.com/?p=11146 http://pharmaexecnews.com/biotechnology/court-clears-generic-allegra-sale/feed/ 0 http://pharmaexecnews.com/biotechnology/nps-soars-positive-ph3-data-orphan-sbs-drug/ http://pharmaexecnews.com/biotechnology/nps-soars-positive-ph3-data-orphan-sbs-drug/#comments Tue, 08 Feb 2011 08:00:53 +0000 admin http://pharmaexecnews.com/?p=11142 http://pharmaexecnews.com/biotechnology/nps-soars-positive-ph3-data-orphan-sbs-drug/feed/ 0